As EMA Chair, Ireland's Nolan Pledges Agility, Responsiveness, Solidarity In Turbulent Times
Executive Summary
Lorraine Nolan has become chair of the European Medicines Agency’s management board.
You may also be interested in...
EMA Begins Setting Up New Bodies To Tackle Drug Shortages
A new EU regulation has come into effect, giving the European Medicines Agency wider powers to monitor, prevent and manage shortages of medicines and medical devices in public health emergencies. A number of steering groups and other bodies and networks are being set up to put the new systems into action.
EMA Wants More Staff For Continuing Pandemic Workload
The more products the European Medicines Agency approves, the more post-authorization applications it receives, leading to an ever-growing spiral in its workload. This, together with the increase in COVID-19-related tasks, new responsibilities in clinical trials and other areas, and a decline in staff numbers over the years, is posing some real resource issues at the agency.
EMA Probe Finds No Link Between GLP-1s And Suicidal Thoughts & Actions
After reviewing the evidence from non-clinical studies, clinical trials, post-marketing surveillance data and other studies, the European Medicines Agency said there was no need to update the product information for 11 diabetes and weight management drugs.